ArticleJournal of orthodontic science2025
Facial soft tissue changes following maxillary skeletal expansion and protraction in growing patients with class III malocclusion: A randomized clinical trial.
Article in Journal of orthodontic science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to assess and contrast the changes in facial soft tissue that occur in growing patients with Class III malocclusion after facemask maxillary protraction with a maxillary skeletal expander (MSE) versus a hybrid Hyrax.
methodsIn this randomized control clinical trial, 30 patients were randomly selected and allocated into three treatment groups: group 1: (
resultsThe control group showed no significant difference in the medians of all the profile facial soft tissue measurements and the frontal facial soft tissue measurements, In the facemask and hybrid hyrax group, there was a significant decrease in the following variables after intervention: Naso-labial angle, Mento-labial angle, FH to AB line angle, Upper lip to E-line, Lower lip to A-B line, and Nose tip. There was a significant increase in the medians of the Upper lip to A-B line, and the Horizontal reference line angle. In the facemask and MSE group, there was a significant decrease in the medians of the FH to AB line, Upper lip to E-line, Lower lip to A-B line, Nose tip, Height of lower third, Proportion of lower to upper lip length, Right outer fifth, and Left outer fifth, and a significant increase in the medians of the Naso-facial, and Upper lip to A-B line. The facemask and hyrax group showed the greatest increase in upper lip to E-line, significantly higher than the control group, but not the MSE group. Lower lip to E-line distance decreased in the MSE group and increased in the hyrax group, with significant differences among groups. The MSE group had the largest decrease in lower lip to AB line, followed by the hyrax group, though the difference was not significant. Significant differences were noted among the three groups for the upper lip to AB line distance and nose tip position.
conclusionThe significant changes observed in various measurements highlight the potential of these treatment protocols to achieve favorable aesthetic and functional outcomes. Both the hybrid hyrax expander-facemask and MSE-facemask protocols are successful in altering the appearance of the facial soft tissues in growing individuals with Class III malocclusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.